
Balchem (BCPC) Stock Forecast & Price Target
Balchem (BCPC) Analyst Ratings
Bulls say
Balchem is expected to continue seeing demand for its specialty performance ingredients and products, with its Human Nutrition and Health segment leading the way with potential heightened awareness of choline's impact on brain health in older adults. The company has seen record sales and a consistent effective tax rate, while also maintaining a solid position with strong financial metrics and a low debt-to-equity ratio. However, there may be risks relating to slower growth, inflation, or inability to launch new products.
Bears say
Balchem is showing strong margin growth, with gross margin increasing by over 14%, but this is offset by rising operating expenses and a modest decline in revenue. Additionally, the company's effective tax rate is expected to rise in the coming quarters. Despite this, Balchem continues to be a strong player in its niche markets and has the potential for growth in its industrial products segment due to geopolitical shifts. However, the decrease in the applicable P/E multiple may limit the stock's potential for near-term gains.
This aggregate rating is based on analysts' research of Balchem and is not a guaranteed prediction by Public.com or investment advice.
Balchem (BCPC) Analyst Forecast & Price Prediction
Start investing in Balchem (BCPC)
Order type
Buy in
Order amount
Est. shares
0 shares